What AI says about Zycubo
Data as of Oct 20, 2026Based on 42 AI responses
Reviewed by Dimitry Apollonsky
AI summary
Zycubo is a copper histidinate injection used to treat Menkes disease in pediatric patients.
Mentioned in
7%
across Zycubo’s markets · since Jul 5
The market map
Biopharma Research Platforms and ServicesMentioned in
- 1Rare Patient VoiceMentioned in 19%Avg. position 208.9
- 1Isomorphic LabsMentioned in 17%Avg. position 28.1
- 1PatiroMentioned in 17%Avg. position 110.5
- 1Evolutionary ScaleMentioned in 15%Avg. position 35.4
- 1MedPanelMentioned in 15%Avg. position 81.6
- 1Insilico MedicineMentioned in 15%Avg. position 13.7
- 1RecursionMentioned in 14%Avg. position 133.0
- 8MarkerDBMentioned in 13%Avg. position 2.9
- 8LuminexMentioned in 13%Avg. position 7.3
- 8NVIDIAMentioned in 13%Avg. position 9.1
- 8Precision for MedicineMentioned in 12%Avg. position 5.0
- 8Quanterix SimoaMentioned in 12%Avg. position 7.2
- 8MsdMentioned in 11%Avg. position 7.0
- 8BioptimusMentioned in 11%Avg. position 11.1
- 90ZycuboMentioned in 2%Avg. position 1362.3
Where Zycubo ranks in AI
Where AI mentions Zycubo
Each engine’s share of its own answers across Zycubo’s markets · since Jul 5
- ChatGPT Search15%
- Google AI Mode0%
Questions and answers
Other brands in Biopharma Research Platforms and Services
Rank
